MGLL and prostate carcinoma: The expression level of MAGL is higher in androgen-independent versus androgen-dependent human prostate cancer cell lines and RNA-interference disruption of MAGL impairs prostate cancer aggressiveness [89], suggesting that 2-AG has a role to play in the aggressiveness of some types of prostate cancer.